ArticleAlzheimer's & dementia (New York, N. Y.)
Advancing therapeutic approaches for agitation: A neurorelational perspective.
Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Agitation is a common, distressing, and difficult-to-treat symptom in dementia, linked to emotional dysregulation and interpersonal stress. Degenerative and compensatory changes in the locus coeruleus-noradrenergic (LC-NA) system have been implicated in agitation in Alzheimer's disease. However, substantial interindividual variability in the emergence of agitation over the course of dementia suggests that neuropathological changes alone are unlikely to fully account for individual differences in susceptibility to agitation. We explore how mentalizing capacity (the ability to understand one's own and others' thoughts, feelings, beliefs, and intentions) in both care recipients and caregivers may influence agitation propensity. Mentalizing supports adaptive emotion regulation and may underpin person-centered care, but becomes less effective under conditions of heightened arousal and interpersonal stress. It is proposed that LC-NA regulation of arousal may influence the capacity to sustain mentalizing under stress, potentially contributing to agitation and increasing the likelihood of escalation of care. Notably, mentalizing may be compromised by different processes in care recipients and caregivers. In care recipients, neurodegeneration may impair mentalizing, potentially in part through dysregulation of the LC-NA system. In caregivers, distress, burden, and emotionally challenging interactions may undermine the capacity to maintain mentalizing. As disease progression is likely to increasingly constrain mentalizing capacity in care recipients, we consider pharmacological modulation of care recipients' LC-NA function and psychosocial interventions to strengthen caregiver mentalizing as complementary and potentially modifiable targets for intervention. This conceptualization is best understood within a relationship-centered care perspective, which extends beyond person-centered care by emphasizing care as embedded in the dynamic relationships between caregivers and care recipients, rather than focusing solely on individual patient preferences. Taken together, these considerations inform a neurorelational framework for understanding and addressing agitation, integrating neurobiological and socio-emotional perspectives to provide a basis for personalized intervention approaches to potentially mitigate the effects of neurodegeneration on "neuropsychiatric reserve."
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.